Search Results - "Ha, Taekyu"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Heat Dissipation of Open-Cell-Type Aluminum Foams Manufactured by Replication-Casting Process by Kim, Jongmin, Ha, Taekyu, Lee, Youngki, Kang, Byungil, Kim, Youngjig

    Published in Metals (Basel ) (01-02-2024)
    “…Open-cell-type aluminum foam demonstrates excellent heat dissipation owing to interconnected pores. In this study, open-cell-type aluminum foams with various…”
    Get full text
    Journal Article
  2. 2

    Mechanical Properties and Deformation Behavior of Open-Cell Type Aluminum Foams with Structural Conditions and Alloy Composition by Kim, Jongmin, Ha, Taekyu, Lee, Youngki, Kang, Byungil, Kim, Youngjig

    Published in Metals (Basel ) (01-08-2024)
    “…Open-cell type aluminum foams with various structural conditions and alloy compositions were manufactured using the replication casting process. The porosity…”
    Get full text
    Journal Article
  3. 3

    Microstructural Analysis on Grain Boundary of Boron– and Zirconium–Containing Wrought Nickel-Based Superalloys by Kang, Byungil, Lee, Youngki, Kim, Jongmin, Ha, Taekyu, Kim, Youngjig

    Published in Crystals (Basel) (01-03-2024)
    “…Trace elements such as boron (B) and zirconium (Zr) can increase creep resistance in nickel-based superalloys. This study investigates the change of…”
    Get full text
    Journal Article
  4. 4

    Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growth by Wang, Yuyi, Salvucci, Ombretta, Ohnuki, Hidetaka, Tran, Andy D, Ha, Taekyu, Feng, Jing‐Xin, DiPrima, Michael, Kwak, Hyeongil, Wang, Dunrui, Yu, Yanlin, Kruhlak, Michael, Tosato, Giovanna

    Published in EMBO molecular medicine (07-07-2021)
    “…The tyrosine phosphatase SHP2 is oncogenic in cancers driven by receptor‐tyrosine‐kinases, and SHP2 inhibition reduces tumor growth. Here, we report that SHP2…”
    Get full text
    Journal Article
  5. 5

    Antisense transcription from lentiviral gene targeting linked to an integrated stress response in colorectal cancer cells by Ha, Taekyu, DiPrima, Michael, Koparde, Vishal, Jailwala, Parthav, Ohnuki, Hidetaka, Feng, Jing-Xin, Palangat, Murali, Larson, Daniel, Tosato, Giovanna

    Published in Molecular therapy. Nucleic acids (14-06-2022)
    “…Advances in gene therapy research have resulted in the successful development of new therapies for clinical use. Here, we explored a gene targeting approach to…”
    Get full text
    Journal Article
  6. 6

    Identification of Eph receptor signaling as a regulator of autophagy and a therapeutic target in colorectal carcinoma by DiPrima, Michael, Wang, Dunrui, Tröster, Alix, Maric, Dragan, Terrades‐Garcia, Nekane, Ha, Taekyu, Kwak, Hyeongil, Sanchez‐Martin, David, Kudlinzki, Denis, Schwalbe, Harald, Tosato, Giovanna

    Published in Molecular oncology (01-11-2019)
    “…Advanced colorectal carcinoma is currently incurable, and new therapies are urgently needed. We report that phosphotyrosine‐dependent Eph receptor signaling…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Tolfenamic acid downregulates β‐catenin in colon cancer by Lee, Seong‐Ho, Ha, Taekyu, Lou, Zhiyuan

    Published in The FASEB journal (01-04-2016)
    “…Abstract only Tolfenamic acid, a nonsteroidal anti‐inflammatory drug (NSAIDs) has been shown to induce apoptosis and suppress cancer cell growth and…”
    Get full text
    Journal Article
  10. 10

    DLC1 deficiency and YAP signaling drive endothelial cell contact inhibition of growth and tumorigenesis by Ritchey, Lisa, Ha, Taekyu, Otsuka, Atsushi, Kabashima, Kenji, Wang, Dunrui, Wang, Yuyi, Lowy, Douglas R., Tosato, Giovanna

    Published in Oncogene (01-11-2019)
    “…Deleted in Liver Cancer 1 (DLC1) is a tumor suppressor gene deleted in many cancers, including angiosarcoma, an aggressive malignancy of endothelial cell…”
    Get full text
    Journal Article
  11. 11

    Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression by Sánchez-Martín, David, Otsuka, Atsushi, Kabashima, Kenji, Ha, Taekyu, Wang, Dunrui, Qian, Xiaolan, Lowy, Douglas R, Tosato, Giovanna

    “…Deleted in Liver Cancer 1 (DLC1) is a tumor suppressor gene frequently deleted in cancer. However, DLC1 is not known to be deleted in angiosarcoma, an…”
    Get full text
    Journal Article
  12. 12

    Potential Dual Role of Activating Transcription Factor 3 in Colorectal Cancer by Jiang, Xiaojing, Kim, Kui-Jin, Ha, Taekyu, Lee, Seong-Ho

    Published in Anticancer research (01-02-2016)
    “…Activating transcription factor 3 (ATF3) is a member of the ATF/CREB transcription factor family and has been proposed as a molecular target for cancer…”
    Get full text
    Journal Article
  13. 13

    ESE‐1 Represses Formation of Tumor in vivo and Growth, Invasion and Migration of Human NSCLC Cells in vitro by Lou, Zhiyuan, Lee, Bok‐Soon, Ha, Taekyu, Xu, Yanrui, Kim, Haeng‐Jun, Kim, Chul‐Ho, Lee, Seong‐Ho

    Published in The FASEB journal (01-04-2018)
    “…Lung cancer is the leading cause of cancer mortality in the United State due to poor prognosis. Identification of effective molecular target is essential for…”
    Get full text
    Journal Article
  14. 14

    Tolfenamic acid downregulates β-catenin in colon cancer by Ha, Taekyu, Lou, Zhiyuan, Baek, Seung Joon, Lee, Seong-Ho

    Published in International immunopharmacology (01-06-2016)
    “…Tolfenamic acid is one of the fenamic acid-derived non-steroid anti-inflammatory drugs (NSAIDs) and has been shown to exhibit anti-cancer activities in several…”
    Get full text
    Journal Article
  15. 15

    Identification of epithelial‐specific ETS‐1 (ESE‐1) as a tumor suppressor and molecular target of green tea compound, EGCG by Ha, Taekyu, Lee, Jihye, Lou, Zhiyuan, Lee, Bok‐Soon, Kim, Chul‐Ho, Lee, Seong‐Ho

    Published in Molecular carcinogenesis (01-06-2019)
    “…Epithelial specific ETS‐1 (ESE‐1) belongs to the E26 transformation‐specific transcription factor superfamily and is of great interest as a potential target…”
    Get full text
    Journal Article
  16. 16

    ESE‑1 suppresses the growth, invasion and migration of human NSCLC cells and tumor formation in vivo by Lou, Zhiyuan, Lee, Bok-Soon, Ha, Taekyu, Xu, Yanrui, Kim, Haeng-Jun, Kim, Chul-Ho, Lee, Seong-Ho

    Published in Oncology reports (01-09-2018)
    “…Lung cancer is the first leading cause of cancer‑related death in the United States. Non‑small cell lung cancer (NSCLC) is the most common type of lung cancer…”
    Get full text
    Journal Article
  17. 17

    ESE-1/ELF3 Is a Tumor Suppressor and Molecular Target of Green Tea Compound, EGCG (P05-009-19) by Ha, Taekyu, Lee, Jihye, Lou, Zhiyuan, Lee, Bok-Soon, Kim, Chul-Ho, Lee, Seong-Ho

    Published in Current developments in nutrition (01-06-2019)
    “…Epithelial Specific ETS-1 (ESE-1), also known as E74-Like Factor 3 (ELF3), belongs to the E26 transformation-specific transcription factor superfamily and is…”
    Get full text
    Journal Article